John Reynolds, MD
Orthopaedic Surgery · Wilmington, DENPI 1508216714
Payments from drug & device makers
What this record shows
This record is dominated by education: $6,869 of the $9,362 with a category attached, or 73.4%. 17 manufacturers reported payments, led by Rock Medical Orthopedics, Inc. at 38.7% of the total. Reporting peaked in 2021 at $3,107 and has fallen 95.0% since, to $156 in 2025.
Across 36 payments — averaging $260.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Rock Medical Orthopedics, Inc.$4K
- Liberty Surgical Inc.$3K
- Axogen$2K
- Medical Device Business Services, Inc.$640
- Stryker$157
- Endo Pharmaceuticals Inc.$121
- plus $396 from 11 others
What the payments were for
- Travel & lodging$1,12912%
- Food & beverage$1,36515%
- Education$6,86973%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Rock Medical Orthopedics, Inc. | 5 | $3,627 |
| Liberty Surgical Inc. | 3 | $2,629 |
| Axogen | 6 | $1,794 |
| Medical Device Business Services, Inc. | 2 | $640 |
| Stryker | 5 | $157 |
| Endo Pharmaceuticals Inc. | 1 | $121 |
| Exsomed Corporation | 1 | $66 |
| Globus Medical | 3 | $56 |
| Eclipse Technology Solutions Inc. | 2 | $52 |
| Integra Lifesciences Corporation | 1 | $48 |
| Flower Orthopedics Coporation | 1 | $43 |
| Radius Health, Inc. | 1 | $30 |
| Sonex Health, Inc. | 1 | $26 |
| Bioventus LLC | 1 | $20 |
| Fidia Pharma USA Inc. | 1 | $19 |
| Smith+Nephew | 1 | $18 |
| Endo USA, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AVANCE NERVE GRAFT$1,703
- XIAFLEX$121
How this compares
$9,362 in reported general payments places this provider in the 60th percentile of 70 orthopaedic surgery providers in Delaware.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 11 | $601 |
| Oxycodone Hcl | 25 | $102 |
| Tramadol Hcl | 54 | $84 |
| Meloxicam | 21 | $45 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Wilmington
- Suken ShahWilmington$2.1M
- Patrick WardWilmington$68K
- Steven DelloseWilmington$52K
- James RubanoWilmington$39K
- Nicholas QuercettiWilmington$32K
- Michael PrincipeWilmington$29K
- David TainterWilmington$26K
- Akul PatelWilmington$21K
- Alfonso ArevaloWilmington$18K
- Michael ShraderWilmington$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.